Peter Barrett's most recent trade in Obsidian Therapeutics Inc. was a trade of 37,653 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Aug. 3, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Obsidian Therapeutics Inc | Dr. Peter Barrett,PhD | Director | 03 Aug 2026 | 37,653 | 37,653 | - | - | Stock Option (Right to Buy) | ||
| Revvity | Dr. Peter Barrett,PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2026 | 1,265 | 28,293 (0%) | 0% | 0 | Common Stock | |
| Revvity | Dr. Peter Barrett,PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2026 | 1,015 | 27,028 (0%) | 0% | 0 | Common Stock | |
| Revvity | Dr. Peter Barrett,PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 1,338 | 26,013 (0%) | 0% | 0 | Common Stock | |
| Revvity | Dr. Peter Barrett,PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 1,074 | 24,675 (0%) | 0% | 0 | Common Stock | |
| Revvity | Dr. Peter Barrett,PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 1,218 | 23,601 (0%) | 0% | 0 | Common Stock | |
| Revvity | Dr. Peter Barrett,PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 977 | 22,383 (0%) | 0% | 0 | Common Stock | |
| Synlogic Inc | Barrett Peter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 24,923 | 24,923 | - | - | Stock Option (right to buy) | |
| Synlogic Inc | Peter Barrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Revvity | Dr. Peter Barrett,PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 955 | 21,406 (0%) | 0% | 0 | Common Stock | |
| Revvity | Dr. Peter Barrett,PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 783 | 20,451 (0%) | 0% | 0 | Common Stock | |
| Synlogic Inc | Peter Barrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 156,130 | 156,130 | - | - | Stock Option (right to buy) | |
| Synlogic Inc | Peter Barrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 27,000 | 27,000 | - | - | Stock Option (right to buy) | |
| Larimar Therapeutics Inc | Dr. Peter Barrett,PhD | Director | 10 May 2022 | 8,300 | 8,300 | - | - | Stock Option (Right to Buy) | ||
| Revvity | Dr. Peter Barrett,PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2022 | 744 | 19,668 (0%) | 0% | 0 | Common Stock | |
| Revvity | Dr. Peter Barrett,PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2022 | 744 | 19,668 (0%) | 0% | 0 | - | |
| Revvity | Dr. Peter Barrett,PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2022 | 610 | 18,924 (0%) | 0% | 0 | Common Stock | |
| Revvity | Dr. Peter Barrett,PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2022 | 610 | 18,924 (0%) | 0% | 0 | - | |
| Synlogic Inc | Peter Barrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 49,334 | 49,334 | - | - | Stock Option (right to buy) |